1-210804143-C-T

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong

The NM_172362.3(KCNH1):​c.1486G>A​(p.Gly496Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 14/24 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

KCNH1
NM_172362.3 missense

Scores

16
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:11

Conservation

PhyloP100: 7.62

Publications

13 publications found
Variant links:
Genes affected
KCNH1 (HGNC:6250): (potassium voltage-gated channel subfamily H member 1) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, subfamily H. This member is a pore-forming (alpha) subunit of a voltage-gated non-inactivating delayed rectifier potassium channel. It is activated at the onset of myoblast differentiation. The gene is highly expressed in brain and in myoblasts. Overexpression of the gene may confer a growth advantage to cancer cells and favor tumor cell proliferation. Alternative splicing of this gene results in two transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
KCNH1 Gene-Disease associations (from GenCC):
  • KCNH1 associated disorder
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Illumina, ClinGen
  • Temple-Baraitser syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Zimmermann-Laband syndrome 1
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Zimmermann-Laband syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 7 uncertain in NM_172362.3
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.984
PP5
Variant 1-210804143-C-T is Pathogenic according to our data. Variant chr1-210804143-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 183418.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_172362.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH1
NM_172362.3
MANE Select
c.1486G>Ap.Gly496Arg
missense
Exon 8 of 11NP_758872.1O95259-1
KCNH1
NM_002238.4
c.1405G>Ap.Gly469Arg
missense
Exon 8 of 11NP_002229.1O95259-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH1
ENST00000271751.10
TSL:2 MANE Select
c.1486G>Ap.Gly496Arg
missense
Exon 8 of 11ENSP00000271751.4O95259-1
KCNH1
ENST00000639952.1
TSL:1
c.1405G>Ap.Gly469Arg
missense
Exon 8 of 11ENSP00000492697.1O95259-2
KCNH1
ENST00000640044.1
TSL:1
c.334G>Ap.Gly112Arg
missense
Exon 4 of 7ENSP00000491434.1A0A1W2PPA2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1460860
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
726652
African (AFR)
AF:
0.00
AC:
0
AN:
33468
American (AMR)
AF:
0.00
AC:
0
AN:
44490
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26104
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39658
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86106
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53368
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111526
Other (OTH)
AF:
0.00
AC:
0
AN:
60374
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
4
-
-
Zimmermann-Laband syndrome 1 (4)
2
-
-
not provided (2)
2
-
-
Temple-Baraitser syndrome (2)
1
-
-
Inborn genetic diseases (1)
1
-
-
See cases (1)
1
-
-
Temple-Baraitser syndrome;C4551773:Zimmermann-Laband syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.56
D
BayesDel_noAF
Pathogenic
0.56
CADD
Pathogenic
34
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.95
D
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.93
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.91
D
M_CAP
Pathogenic
0.75
D
MetaRNN
Pathogenic
0.98
D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
4.1
H
PhyloP100
7.6
PrimateAI
Pathogenic
0.93
D
PROVEAN
Pathogenic
-7.1
D
REVEL
Pathogenic
0.99
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.97
MutPred
0.91
Gain of catalytic residue at G496 (P = 0.0329)
MVP
0.99
MPC
2.8
ClinPred
1.0
D
GERP RS
5.7
Varity_R
0.96
gMVP
1.0
Mutation Taster
=5/95
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.20
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.20
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs730882175; hg19: chr1-210977485; COSMIC: COSV55098016; API